News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen Class of 2024
Insights
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Jobs
Career Advice
Companies
Hotbeds
More
Employer Resources
Best Places to Work
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
178,286 Results
Type
Article (17165)
Company Profile (124)
Press Release (160997)
Section
Business (58099)
Career Advice (918)
Deals (9338)
Drug Delivery (30)
Drug Development (23446)
Employer Resources (70)
FDA (2379)
Job Trends (4212)
News (92174)
Policy (5835)
Tag
Academia (480)
Africa (322)
Alliances (16112)
Alzheimer's disease (329)
Antibody-drug conjugate (ADC) (39)
Approvals (2345)
Arizona (23)
Artificial intelligence (35)
Asia (13196)
Australia (2593)
Bankruptcy (75)
Best Places to Work (2778)
Biotechnology (109)
C2C Services and Suppliers (8273)
California (667)
Canada (303)
Cancer (148)
Career advice (738)
CAR-T (33)
Cell therapy (69)
China (50)
Clinical research (17743)
Collaboration (75)
Connecticut (26)
COVID-19 (705)
Cystic fibrosis (26)
Data (59)
Diagnostics (997)
Diversity, equity & inclusion (21)
Earnings (15316)
Employer resources (67)
Europe (29356)
Events (30040)
Executive appointments (69)
FDA (2414)
Florida (64)
Funding (58)
Gene editing (20)
Gene therapy (48)
GLP-1 (212)
Government (589)
Healthcare (2376)
Hotbed/Location (114751)
Illinois (68)
Indiana (42)
Infectious disease (712)
Inflammatory bowel disease (40)
Interviews (131)
IPO (4018)
Job creations (1472)
Job search strategy (693)
Layoffs (118)
Legal (1171)
Lung cancer (30)
Management (21)
Manufacturing (37)
Maryland (108)
Massachusetts (496)
Medical device (805)
Medtech (806)
Mergers & acquisitions (5297)
Metabolic disorders (81)
Michigan (42)
Minnesota (73)
Neuroscience (390)
New Jersey (200)
New York (167)
NextGen Class of 2024 (1439)
Non-profit (450)
North Carolina (193)
Northern California (288)
Obesity (45)
Ohio (26)
Opinion (156)
Patents (28)
Pennsylvania (174)
People (21466)
Phase I (6849)
Phase II (8440)
Phase III (4826)
Pipeline (37)
Policy (26)
Postmarket research (333)
Preclinical (2782)
Press Release (61)
Rare diseases (55)
Real estate (2435)
Recruiting (35)
Regulatory (4288)
Research institute (516)
Resumes & cover letters (147)
Series A (20)
South America (394)
Southern California (283)
Startups (1777)
Texas (48)
United States (2661)
Vaccines (134)
Washington State (166)
Weight loss (48)
Date
Today (35)
Last 7 days (234)
Last 30 days (753)
Last 365 days (12971)
2024 (8955)
2023 (13261)
2022 (16128)
2021 (17022)
2020 (13298)
2019 (9648)
2018 (7641)
2017 (9049)
2016 (8163)
2015 (9503)
2014 (9811)
2013 (9529)
2012 (6159)
2011 (6530)
2010 (5986)
178,286 Results for "pci biotech".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
PCI Biotech first half 2024 interim results
August 28, 2024
·
3 min read
Business
Biotech Industry Overcomes Slump, Adapts to New Normal
M&A activity surges and IPOs return as the biotech industry navigates a changing business landscape marked by strategic consolidation and renewed investor focus on innovation.
August 14, 2024
·
6 min read
·
Ana Mulero
Pharm Country
Aldena Therapeutics Selects PCI Pharma Services to Manufacture and Distribute Innovative Investigational Treatment for Dermatological Diseases
Aldena Therapeutics has chosen PCI Pharma Services, a world-leading global contract development and manufacturing organization to formulate, package, and distribute ALD-102, an siRNA-based investigational injectable treatment for inflammatory dermatological conditions, all under one roof at PCI’s San Diego facility.
October 19, 2023
·
4 min read
Mergers & acquisitions
Recursion, Exscientia Merge to Create AI-Enabled Biotech
Armed with a combined $850 million in cash, the companies said Thursday the resulting biotech will have a pipeline that could deliver 10 clinical readouts over the next 18 months.
August 8, 2024
·
2 min read
·
Nick Paul Taylor
Career Advice
7 Biotech Companies Hiring in San Diego
Looking for a biotech job in San Diego? Check out these seven top companies hiring life sciences professionals like you.
July 18, 2024
·
1 min read
·
Angela Gabriel
Career Advice
Career Coach: Transition Into a Career in Biotech
This week, Carina discusses how to transition into a career in biotech when you don’t have lab experience. Plus, handling difficult interviews and getting a “dry” promotion.
July 16, 2024
·
5 min read
·
Carina Clingman
Sponsored
SignalChem Biotech, World Leader in Kinases, Is Now Part of Sino Biological
Sino Biological, Inc. has successfully concluded the acquisition of Vancouver-based Canadian biotechnology company SignalChem Biotech Inc.
July 15, 2024
·
3 min read
Business
Mymetics and PCI Biotech Sign a Preclinical Research Collaboration
Mymetics Corporation and PCI Biotech have entered into a preclinical research collaboration with the aim to explore technological synergies for the possible enhancement of cancer therapy.
August 31, 2022
·
2 min read
Kane Biotech Makes First Commercial Sale of revyve™ Antimicrobial Wound Gel to Progena
Kane Biotech Inc. (TSX- V:KNE; OTCQB:KNBIF) (“Kane Biotech” or “Kane”) announces that it has made its first commercial-scale sale of revyve™ Antimicrobial Wound Gel product (“revyve™”) to ProgenaCare Global LLC (“ProgenaCare”).
June 27, 2024
·
4 min read
Deals
Lilly Inks Radiopharma Deal With Radionetics, Secures Right to Buy Biotech
Eli Lilly is expanding its radiopharmaceutical portfolio with a $140 million upfront payment to Radionetics Oncology and the exclusive future right to acquire the biotech for $1 billion.
July 2, 2024
·
2 min read
·
Tristan Manalac
1 of 17,829
Next
